✦ LIBER ✦

A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia

✍ Scribed by Nihad A.M. Tamimi; Ivan Mincik; Scott Haughie; Janice Lamb; Anna Crossland; Peter Ellis

Book ID: 110922751
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 284 KB
Volume: 106
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2010.09204.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: A Placebo-Controlled Study Investiga

Re: A Placebo-Controlled Study Investigating the Efficacy and Safety of the Phosphodiesterase Type 5 Inhibitor UK-369,003 for the Treatment of Men With Lower Urinary Tract Symptoms Associated With Clinical Benign Prostatic Hyperplasia

✍ Kaplan, Steven A. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 107 KB

A placebo-controlled exploratory study i

A placebo-controlled exploratory study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with storage lower urinary tract symptoms associated with a clinical diagnosis of overactive bladder

✍ Francois A. Giuliano; Janice Lamb; Anna Crossland; Scott Haughie; Peter Ellis; N 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Long-term Safety and Efficacy of Tamsulo

Long-term Safety and Efficacy of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

✍ NARAYAN, PERINCHERY; EVANS, CHRISTOPHER P.; MOON, TIMOTHY 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 424 KB

Efficacy and safety of once-daily alfuzo

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial

✍ Claus G Roehrborn 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 125 KB

EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIB

EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIBITOR USE ON LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS FROM THE BPH REGISTRY

✍ Rosen, Raymond C; Wei, John T; Miner, Martin; Roehrborn, Claus G; Seftel, Allen 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 162 KB

THE EFFICACY AND SAFETY OF TADALAFIL ADM

THE EFFICACY AND SAFETY OF TADALAFIL ADMINISTERED ONCE A DAY FOR LOWER URINARY TRACT SYMPTOMS (LUTS) IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH)

✍ K. Mc Vary; C. Roehrborn; J. Kaminetsky; S. Auerbach; B. Wachs; J. Young; A. Esl 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB